Health-related quality of life and survival of patients with hepatocellular carcinoma treated with transarterial chemoembolization and Yttrium-90
Treatment with TACE and Y<sup>90</sup> was similar with regard to survival. However, TACE showed statistically and clinically meaningful benefits in physical, social/family, and emotional well-being. Further research is warranted to identify profiles of patients who may demonstrate a preferential response to either TACE or Y<sup>90</sup>.
Authors
- J. Wallis Marsh (ORCID: https://orcid.org/0000-0003-4681-1012)
- Cramer J. Kallem (ORCID: https://orcid.org/0000-0002-4835-0363)
- Kathryn Bress
- Patrick Bou‐Samra (ORCID: https://orcid.org/0000-0002-6397-5644)
- David A. Geller (ORCID: https://orcid.org/0000-0003-0735-1068)
- Allan Tsung (ORCID: https://orcid.org/0000-0002-3916-8965)
- Jennifer L. Steel (ORCID: https://orcid.org/0000-0001-9520-963X)
- Ellie Gammer
Institutions
- University of Pittsburgh (US)
- UPMC Health System (US)
- University of Pittsburgh Medical Center (US)
Publication Details
- Journal
- Journal of the Egyptian National Cancer Institute
- Published
- 2025-04-13
- DOI
- https://doi.org/10.1186/s43046-025-00267-1
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.64
Funders
- National Cancer Institute